Search research articles
Contact Us
Filters
Showing results (271-280 of 430) with videos related to
Page
of 43
Sort By:
Science Translational Medicine
|
January 4, 2019
Nanoscavenger provides long-term prophylactic protection against nerve agents in rodents
Peng Zhang, Erik J Liu, Caroline Tsao, et al.
Veterinary Surgery : VS
|
September 11, 2020
Diagnostic accuracy of optical coherence tomography for assessing surgical margins of canine soft tissue sarcomas in observers of different specialties
Josephine A Dornbusch, Laura E Selmic, Pin-Chieh Huang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 24, 2013
Prognosis of women with primary breast cancer diagnosed during pregnancy: results from an international collaborative study
Frédéric Amant, Gunter von Minckwitz, Sileny N Han, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 8, 2010
An aCGH classifier derived from BRCA1-mutated breast cancer and benefit of high-dose platinum-based chemotherapy in HER2-negative breast cancer patients
M A Vollebergh, E H Lips, P M Nederlof, et al.
Breast Care (Basel, Switzerland)
|
June 15, 2022
Risk-Adjusted Cancer Screening and Prevention (RiskAP): Complementing Screening for Early Disease Detection by a Learning Screening Based on Risk Factors
Rita K Schmutzler, Björn Schmitz-Luhn, Bettina Borisch, et al.
Cancer Research
|
March 21, 2020
Endonuclease FEN1 Coregulates ERα Activity and Provides a Novel Drug Interface in Tamoxifen-Resistant Breast Cancer
Koen D Flach, Manikandan Periyasamy, Ajit Jadhav, et al.
The Journal of Experimental Medicine
|
August 29, 2023
MYC is a clinically significant driver of mTOR inhibitor resistance in breast cancer
Jinhyuk Bhin, Julia Yemelyanenko, Xue Chao, et al.
Cancer
|
June 18, 2016
A randomized phase 2 study exploring the role of bevacizumab and a chemotherapy-free approach in HER2-positive metastatic breast cancer: The HAT study (BOOG 2008-2003), a Dutch Breast Cancer Research Group trial
Jan C Drooger, Harm van Tinteren, Steffen M de Groot, et al.
JAMA Network Open
|
February 26, 2025
Genetic Alterations, Therapy Response, and Survival Among Patients With Triple-Negative Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial
Lisa Richters, Oleg Gluz, Nana Weber-Lassalle, et al.
The Journal of Molecular Diagnostics : JMD
|
January 1, 2014
MammaPrint molecular diagnostics on formalin-fixed, paraffin-embedded tissue
Anna Sapino, Paul Roepman, Sabine C Linn, et al.
Page
of 43
Search research articles
Search
Showing results (271-280 of 430) with videos related to
Sort By:
Page
of 43
Science Translational Medicine
|
January 4, 2019
Nanoscavenger provides long-term prophylactic protection against nerve agents in rodents
Peng Zhang, Erik J Liu, Caroline Tsao, et al.
Veterinary Surgery : VS
|
September 11, 2020
Diagnostic accuracy of optical coherence tomography for assessing surgical margins of canine soft tissue sarcomas in observers of different specialties
Josephine A Dornbusch, Laura E Selmic, Pin-Chieh Huang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 24, 2013
Prognosis of women with primary breast cancer diagnosed during pregnancy: results from an international collaborative study
Frédéric Amant, Gunter von Minckwitz, Sileny N Han, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 8, 2010
An aCGH classifier derived from BRCA1-mutated breast cancer and benefit of high-dose platinum-based chemotherapy in HER2-negative breast cancer patients
M A Vollebergh, E H Lips, P M Nederlof, et al.
Breast Care (Basel, Switzerland)
|
June 15, 2022
Risk-Adjusted Cancer Screening and Prevention (RiskAP): Complementing Screening for Early Disease Detection by a Learning Screening Based on Risk Factors
Rita K Schmutzler, Björn Schmitz-Luhn, Bettina Borisch, et al.
Cancer Research
|
March 21, 2020
Endonuclease FEN1 Coregulates ERα Activity and Provides a Novel Drug Interface in Tamoxifen-Resistant Breast Cancer
Koen D Flach, Manikandan Periyasamy, Ajit Jadhav, et al.
The Journal of Experimental Medicine
|
August 29, 2023
MYC is a clinically significant driver of mTOR inhibitor resistance in breast cancer
Jinhyuk Bhin, Julia Yemelyanenko, Xue Chao, et al.
Cancer
|
June 18, 2016
A randomized phase 2 study exploring the role of bevacizumab and a chemotherapy-free approach in HER2-positive metastatic breast cancer: The HAT study (BOOG 2008-2003), a Dutch Breast Cancer Research Group trial
Jan C Drooger, Harm van Tinteren, Steffen M de Groot, et al.
JAMA Network Open
|
February 26, 2025
Genetic Alterations, Therapy Response, and Survival Among Patients With Triple-Negative Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial
Lisa Richters, Oleg Gluz, Nana Weber-Lassalle, et al.
The Journal of Molecular Diagnostics : JMD
|
January 1, 2014
MammaPrint molecular diagnostics on formalin-fixed, paraffin-embedded tissue
Anna Sapino, Paul Roepman, Sabine C Linn, et al.
Page
of 43